0001640455-21-000029.txt : 20210203 0001640455-21-000029.hdr.sgml : 20210203 20210203174843 ACCESSION NUMBER: 0001640455-21-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURRAY RICHARD /CA/ CENTRAL INDEX KEY: 0001242935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 21587572 MAIL ADDRESS: STREET 1: 22643 WOODRIDGE CT CITY: CUPERTINO STATE: CA ZIP: 95014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_161239250703335.xml FORM 4 X0306 4 2021-02-01 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001242935 MURRAY RICHARD /CA/ C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 1 1 0 0 CEO and President Common Stock 2021-02-01 4 A 0 75000 0 A 215371 D Common Stock 2021-02-03 4 A 0 7500 0 A 222871 D Stock Option (Right to Buy) 11.89 2021-02-01 4 A 0 150000 0 A 2031-02-01 Common Stock 150000.0 150000 D Stock Option (Right to Buy) 12.67 2021-02-01 4 A 0 15000 0 A 2031-02-03 Common Stock 15000.0 15000 D The option will vest quarterly in 16 equal installments following January 1, 2021. /s/ Kim C. Drapkin, Attorney-in-Fact 2021-02-03